Infectious Disorders - Drug Targets

Author(s): Naina Mohamed Pakkir Maideen*, Rajkapoor Balasubramanian, Gobinath Manavalan, Kumar Balasubramanian, Nivedhitha Subramanian, Thirumal Murugesan and Vasanth Kumar Solaimalai

DOI: 10.2174/1871526522666220321152504

DownloadDownload PDF Flyer Cite As
An Insight of Clinical Evidence of Ayurveda Interventions in the Management of COVID-19 Patients

Article ID: e210322202491 Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: Coronavirus disease 2019 (COVID-19) was caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and patients with COVID-19 may be treated with traditional medicine like Ayurveda alone or in combination with standard allopathic treatment, as Ayurveda is one of the oldest traditional medicinal systems followed by millions around the world.

Methods: The literature was searched in databases such as LitCOVID, Google Scholar, Science Direct, EBSCO, Scopus, Web of Science, EMBASE, and reference lists to identify articles relevant to the use of Ayurvedic medicines in the management of COVID-19.

Results: Several clinical studies have determined the efficacy of Ayurvedic medicines and formulations in the management of patients with COVID-19.

Conclusion: The Ayurvedic medicines and formulations with antiviral, antioxidant, anti-inflammatory, and immunomodulatory properties could be used along with standard allopathic medicines to assist in the earlier detection of virus, speedy recovery of patients with COVID-19, faster discharge from hospitals, and the prevention of further deterioration.

Keywords: SARS CoV-2, COVID-19, ayurvedic medicines, shamshamani vati, chyawanprash, ashwagandha (Withania somnifera), guduchi (Tinospora cordifolia), pippali (Piper longum), anuthaila, agastya haritaki rasayana, Triphala churna, Rasayana churna.